- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cohance Lifesciences Limited — Updates, 06-02-2026: General Updates
06-02-2026 | 07:53 pm
06-02-2026 | 07:53 pm
Cohance Lifesciences received a US FDA Warning Letter for its Hyderabad FDF unit. This facility contributes less than 2% to FY25 consolidated revenue and under 1% to EBITDA, indicating a contained financial impact. The company is actively implementing corrective actions.
No comments yet. Be the first to comment!